Send feedback

FSHR p.Arg573Cys

c.1717C>T · rs121909660 · VCV16245

Pathogenic No assertion criteria
Classification
Pathogenic
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2716 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0011%, nfe)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
ovarian dysgenesis 1

Computational evidence

Protein change
AlphaMissense0.2716likely benign ⚠ discordant with ClinVar
REVEL0.763pathogenic-leaning
SaProtLLR -12.37damaging
⇒ REVEL and SaProt call this damaging; AlphaMissense does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.5GERP 2.3, phastCons 1
Regional constrainto/e 1.16unconstrained · MANE · 192 kb · p 7.5e-06 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0011% European (non-Finnish) · 13/1,179,986 alleles
Filtering AF 0.000615% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000474%
Overall 0.000867% 14/1,614,066 alleles · very rare exomes 14/1,461,814 · genomes 0/152,252 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0011% 90,768
South Asian 0.0011% 91,068

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FSHR
Protein
p.Arg573Cys
Coding
c.1717C>T
MANE Select
NM_000145
dbSNP
rs121909660
Type
single nucleotide variant
Location
chr2:48963104 (GRCh38)
Gene constraint
LOEUF 1.071 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.87 · 5 PDB
Residue 573
an α-helix; a UniProt-annotated variant site (in odg1; alters signal transduction of the receptor; adenylate cyclase stimulation by fsh is 24 +-4% residual activity)
Full FSHR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fshr-p-arg573cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown